19 patients in the treatment group and 18 in the placebo group completed the trial
This chronic low-grade hepatic inflammation contributes to MASLD pathology [101, 102]
Roles of inflammasomes in epstein-barr virus-associated nasopharyngeal cancer
Areas of hyperpigmentation and hypopigmentation of the skin develop later in life, and BCC or SCC can develop at an early age.[207] Reports of multiple SCCs in situ have been reported in individuals as young as 16 years.[208] The precise increased risk of skin cancer is not well characterized, but the point prevalence of keratinocyte carcinomas, including both BCC and SCC, is 2% to 5% in young individuals affected by this syndrome.[209] This prevalence is clearly greater than that found in individuals in the same age group in the general population
New England Journal of Medicine, 384(11), 9891002
Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study.[J]